Details for New Drug Application (NDA): 062731
✉ Email this page to a colleague
NDA 062731 describes MYKINAC, which is a drug marketed by Alpharma Us Pharms and is included in two NDAs. Additional details are available on the MYKINAC profile page.
The generic ingredient in MYKINAC is nystatin. There are eight drug master file entries for this compound. Forty-one suppliers are listed for this compound. Additional details are available on the nystatin profile page.
The generic ingredient in MYKINAC is nystatin. There are eight drug master file entries for this compound. Forty-one suppliers are listed for this compound. Additional details are available on the nystatin profile page.
Summary for 062731
| Tradename: | MYKINAC |
| Applicant: | Alpharma Us Pharms |
| Ingredient: | nystatin |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 062731
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | OINTMENT;TOPICAL | Strength | 100,000 UNITS/GM | ||||
| Approval Date: | Sep 22, 1986 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
